Naramig (Naratriptan)

Naratriptan, the active ingredient in Naramig, is a Triptan presented as an oral tablet for oral use. It is indicated for the acute treatment of migraine attacks in adults. By targeting specific serotonin receptors, it helps relieve headache pain and associated symptoms such as nausea, photophobia, and phonophobia.

GNH USA supplies Naramig as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our quality‑assured manufacturing follows EU standards, ensuring consistent potency and safety for patients across global markets.

Naratriptan is a Triptan used in the migraine pathway to treat acute migraine attacks.

Migraine: provides rapid relief of headache pain and associated symptoms during an acute migraine episode. Migraine with aura: alleviates headache and visual disturbances that accompany aura phases. Acute episodic migraine: reduces the severity and duration of single migraine attacks when taken at onset.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Fatigue: feeling unusually tired. - Tingling or numbness: usually in extremities. - Dry mouth: reduced salivation. - Chest discomfort: mild pressure or tightness.

Serious or Rare Side Effects: - Coronary artery spasm: severe chest pain requiring immediate attention. - Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities when combined with other serotonergic agents. - Severe hypertension: sudden rise in blood pressure. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Cardiac arrhythmias: irregular heart rhythms. - Myocardial infarction: rare heart attack events.

Before prescribing Naratriptan, consider the following precautions: - Cardiovascular assessment: evaluate history of heart disease, ischemia, or uncontrolled hypertension. - Drug interactions: avoid concomitant use with ergotamine or other triptans. - Age considerations: safety not fully established in elderly populations. - Pregnancy: use only if potential benefit justifies potential risk to the fetus. - Renal or hepatic impairment: dose adjustment may be required based on clinical judgment. - Store below 25°C: keep in the original pack, protect from moisture.

Naratriptan may interact with several medication classes.

Major Interactions (Avoid): - Ergot derivatives: combined use can cause severe vasospasm. - MAO inhibitors: increased risk of serotonin syndrome. - SSRIs, SNRIs, or other serotonergic agents: heightened serotonin toxicity. - Other triptans: additive vasoconstrictive effects. - Strong CYP1A2 inhibitors: may raise naratriptan plasma levels.

Moderate Interactions (Monitor Closely): - Antihypertensives: possible additive blood pressure lowering. - Oral contraceptives: may affect efficacy of migraine control. - Antihistamines: could increase sedation. - Moderate CYP3A4 inhibitors: may modestly increase drug exposure. - NSAIDs: monitor for gastrointestinal irritation.